Cell Therapy in Women's Health

Phase 1

Recruiting

• Conditions: Stress urinary incontinence; C12.777.934.852.249

• Registration Number: RBR-29x2pr
• Lead Sponsor: niversidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion criteria.
1. Patients with moderate primary and refractory stress urinary incontinence confirmed by stress cough test; or during urodynamic study; or during the pad test.

Exclusion Criteria

Exclusion Criteria
Patients with prolapse of anterior or uterine vaginal wall greater than stage 2 POP-Q;
Patients submitted to surgical procedures to repair previous SUI;
Patients with genital malformations that make it impossible to inject at the site of
middle third of the urethra;
Patients submitted to previous pelvic radiotherapy;
Patients who during clinical evaluation or urodynamics present other
diagnoses that not only SUI;
Patients who did not agree to participate in the study at any stage or the ones who are not able to read, write and understand the study;
Patients <18 years of age.

Study & Design

• Study Type: Intervention
• Study Design: Not specified